VolitionRX Ltd. Daily Stock Analysis

Daily Stock Analysis, VNRX, VolitionRX Ltd, priceseries

VolitionRX Ltd. Daily Stock Analysis
Stock Information
Open
2.70
Close
2.58
High
2.70
Low
2.56
Previous Close
2.64
Daily Price Gain
-0.06
YTD High
3.30
YTD High Date
Jan 3, 2022
YTD Low
2.38
YTD Low Date
Jan 28, 2022
YTD Price Change
-0.65
YTD Gain
-20.12%
52 Week High
4.29
52 Week High Date
Mar 23, 2021
52 Week Low
2.38
52 Week Low Date
Jan 28, 2022
52 Week Price Change
-1.26
52 Week Gain
-32.81%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Oct 30. 2017
2.47
Nov 20. 2017
3.38
15 Trading Days
37.02%
Link
LONG
Jan 16. 2018
2.91
Jan 30. 2018
3.51
10 Trading Days
20.79%
Link
LONG
Sep 19. 2018
2.28
Oct 10. 2018
2.65
15 Trading Days
16.30%
Link
LONG
Jan 29. 2019
2.52
Feb 13. 2019
2.91
11 Trading Days
15.64%
Link
LONG
Jul 23. 2019
3.78
Aug 5. 2019
4.01
9 Trading Days
6.15%
Link
LONG
Mar 20. 2020
2.96
Mar 27. 2020
3.12
5 Trading Days
5.49%
Link
LONG
Dec 15. 2020
3.54
Dec 29. 2020
3.84
9 Trading Days
8.41%
Link
LONG
Feb 1. 2021
4.80
Feb 10. 2021
5.35
7 Trading Days
11.51%
Link
Company Information
Stock Symbol
VNRX
Exchange
NYSE MKT
Company URL
http://www.volitionrx.com
Company Phone
1 (646) 650-1351
CEO
Cameron John Reynolds
Headquarters
-
Business Address
1 SCOTTS RD #24-05 SHAW CENTRE, SINGAPORE, SINGAPORE 228208
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Laboratories & Research
CIK
0000093314
About

VolitionRX Ltd. engages in the development of blood-based cancer tests. Its tests are based on the science of Nucleosomics, which identifies and measures nucleosomes in the bloodstream or other bodily fluid. Its product Nu.Q is a Colorectal Cancer Screening Triage Test. The company was founded on August 5, 2010 and is headquartered in Singapore.

Description

VolitionRx Limited, a life sciences company, focuses on developing blood-based tests to diagnose a range of cancers. The company is involved in the development of epigenetic Nu.Q blood assays based on its Nucleosomics biomarker discovery platform. It develops blood assays in the Nu.Q-X family to detect nucleosomes containing specific nucleotides; and blood assays in the Nu.Q-V family to detect nucleosomes containing specific histone variants. The company also develops blood assays in the Nu.Q-M family to detect nucleosomes containing modified histones that are proteins for packaging and ordering DNA into nucleosomes; blood assays in the Nu.Q-A family to detect nucleosome-protein adducts; and a Nu.Q-T assay to detect cancer by detecting total blood nucleosome levels. In addition, it develops HyperGenomics tissue and blood-based tests to determine disease subtype following initial diagnosis and to decide appropriate therapy; NuQ tests for non-cancer conditions; and NuQ clinical diagnostic products. VolitionRX Limited is based in Singapore.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading